These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32963679)

  • 21. Pediatric TB Management under RNTCP: What and Why?
    Singh V
    Indian J Pediatr; 2019 Aug; 86(8):707-713. PubMed ID: 31250349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview/update IMA GFATM RNTCP PPM project.
    Chugh S
    J Indian Med Assoc; 2008 Mar; 106(3):176, 178, 180. PubMed ID: 18712138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment outcome of neuro tuberculosis patients put on DOTS--an observation study from the field.
    Venugopal K; Sreelatha PR; Philip S; Kumar V
    Indian J Tuberc; 2008 Oct; 55(4):199-202. PubMed ID: 19295107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Status report on DOTS expansion and implementation during the 4th quarter 2003.
    Chauhan LS
    J Indian Med Assoc; 2004 May; 102(5):256-7, 281. PubMed ID: 15636028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative.
    Bhargava A; Jain Y
    Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041
    [No Abstract]   [Full Text] [Related]  

  • 27. Tuberculosis: current situation, challenges and overview of its control programs in India.
    Sandhu GK
    J Glob Infect Dis; 2011 Apr; 3(2):143-50. PubMed ID: 21731301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of pediatric tuberculosis under the Revised National Tuberculosis Control Program (RNTCP).
    Chauhan LS; Arora VK; ;
    Indian Pediatr; 2004 Sep; 41(9):901-5. PubMed ID: 15475631
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of microbiological status after successful completion of intermittent revised national tuberculosis control programme directly observed treatment, short course regimen for microbiologically confirmed pulmonary tuberculosis cases: While new daily regimen going to be implemented in India.
    Ghosh R; Roy S; Rashid MK
    Indian J Med Microbiol; 2018; 36(2):251-256. PubMed ID: 30084420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness.
    Pantoja A; Lönnroth K; Lal SS; Chauhan LS; Uplekar M; Padma MR; Unnikrishnan KP; Rajesh J; Kumar P; Sahu S; Wares F; Floyd K
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):705-12. PubMed ID: 19460245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decadal impact of Directly Observed Treatment Short course program on age and gender among New Infectious Tuberculosis cases in Delhi.
    Anand T; Sharma N; Chandra S; Ingle GK; Grover S
    Indian J Tuberc; 2017 Oct; 64(4):291-295. PubMed ID: 28941851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profile of geriatric patients under DOTS in Revised National Tuberculosis Control Programme.
    Arora VK; Singla N; Sarin R
    Indian J Chest Dis Allied Sci; 2003; 45(4):231-5. PubMed ID: 12962456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 50 years of tuberculosis control in India: progress, pitfalls and the way forward.
    John TJ; Vashishtha VM; John SM
    Indian Pediatr; 2013 Jan; 50(1):93-8. PubMed ID: 23396780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients pathways to tuberculosis diagnosis and treatment in a fragmented health system: a qualitative study from a south Indian district.
    Yellappa V; Lefèvre P; Battaglioli T; Devadasan N; Van der Stuyft P
    BMC Public Health; 2017 Aug; 17(1):635. PubMed ID: 28778192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revised National Tuberculosis Control Programme (RNTCP).
    Muruganathan A; Thomas A; Muniyandi M; Chandrasekaran V
    J Indian Med Assoc; 2010 Dec; 108(12):868-70. PubMed ID: 21661468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Counting the lives saved by DOTS in India: a model-based approach.
    Mandal S; Chadha VK; Laxminarayan R; Arinaminpathy N
    BMC Med; 2017 Mar; 15(1):47. PubMed ID: 28253922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current trends in chemotherapy of tuberculosis.
    Jawahar MS
    Indian J Med Res; 2004 Oct; 120(4):398-417. PubMed ID: 15520489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. India's Revised National Tuberculosis Control Programme: looking beyond detection and cure.
    Kelkar-Khambete A; Kielmann K; Pawar S; Porter J; Inamdar V; Datye A; Rangan S
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):87-92. PubMed ID: 18173883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues.
    Kumar A; Kumar AM; Gupta D; Kanchar A; Mohammed S; Srinath S; Tripathy S; Rajasekaran S; Chan PL; Swaminathan S; Dewan PK
    Int J Tuberc Lung Dis; 2012 May; 16(5):573-8. PubMed ID: 22507931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis mortality trends in Delhi after implementation of RNTCP.
    Dhingra VK; Aggarwal N; Chandra S; Vashist RP
    Indian J Tuberc; 2009 Apr; 56(2):77-81. PubMed ID: 19810589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.